The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010

Diabetes Care

Volumn 36, Issue 8, 2013, Pages 2271-2279

  Casagrande, Sarah Stark ^a   Fradkin, Judith E ^b   Saydah, Sharon H ^c   Rust, Keith F ^d   Cowie, Catherine C ^b  

^a SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; EDUCATION; FEMALE; HISPANIC; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PREVALENCE; VERY ELDERLY; AFRICAN AMERICAN; BLOOD; CAUCASIAN; METABOLISM; MEXICAN AMERICAN; MIDDLE AGED; MOTIVATION; NUTRITION; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN AMERICANS; BLOOD PRESSURE; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GOALS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEXICAN AMERICANS; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; UNITED STATES;

EID: 84882254968     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2258     Document Type: Article

References (25)

1. National Center for Health Statistics, Division of Health Interview Statistics. Crude and Age-Adjusted Percentage of Civilian, Noninstitutionalized Adults with Diagnosed Diabetes, United States, 1980-2010. National Center for Chronic Disease Prevention and Health Promotion, Ed. Atlanta, GA, Centers for Disease Control and Prevention, Division of Diabetes Translation, 2012
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
3. American Diabetes Association. Standards of medical care in diabetesd2011.Diabetes Care 2011;34(Suppl. 1):S11-S61
4. National Institute of Diabetes and Digestive and Kidney Diseases and The Centers for Disease Control and Prevention. National Diabetes Education Program [Internet], 2011. Available from http://www.ndep.nih.gov/. Accessed 1 February 2011
5. Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med 2009;122:443-453
6. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342
7. Mann D, Reynolds K, Smith D, Muntner P. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother 2008;42:1208-1215
8. Centers for Disease Control and Prevention, National Center for Health Statistics. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey. Hyattsville, MD, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1999-2010
9. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey Examination Protocol. Hyattsville, MD, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008
10. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey Laboratory Protocol: Cholesterol and Triglycerides. Hyattsville, MD, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008
11. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
12. National Center for Health Statistics. Laboratory manual for creatinine [Internet], 2008. Available from http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/ lab-methods-05-06.htm. Accessed 15 December 2012
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
14. Hansson L, Zanchetti A, Carruthers SG, et al.HOT StudyGroup. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-1762
15. Pyǒrälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614-620
16. Kuznik A, Mardekian J. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. Cardiovasc Diabetol 2011;10:31
17. Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008;168:2088-2094
18. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
19. Bertoni AG, Clark JM, Feeney P, et al.; Look AHEAD Research Group. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications 2008;22:1-9
20. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med 2009;150:505-515
21. Dorsey R, Songer T. Lifestyle behaviors and physician advice for change among overweight and obese adults with prediabetes and diabetes in the United States, 2006. Prev Chronic Dis 2011;8:A132
22. Wing RR, Phelan S. Long-termweight loss maintenance. Am J Clin Nutr 2005;82 (Suppl.):222S-225S
23. Saydah S, Cowie C, Eberhardt MS, De Rekeneire N, Narayan KM. Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis 2007;17: 529-535
24. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
25. National Center for Health Statistics. Updated advisory for NHANES hemoglobin A1c (Glycohemoglobin) data (revised March 2012) [Internet], 2012. Available from http://www.cdc.gov/nchs/data/nhanes/A1c-webnotice.pdf. Accessed 20 April 2012 Kidney Diseases